Evaluating the Effect of the Use of Virtual Reality Headset in School Vaccinations
1 other identifier
interventional
169
1 country
1
Brief Summary
This study was conducted with a randomized controlled experimental design to determine the effect of virtual reality headset on children's fear and anxiety during vaccinations. Research Hypotheses: Hypothesis 0a (H0a): There is no difference in fear scores between the experimental group in which virtual reality glasses were used during vaccination administration and the control group. Hypothesis 1a (H1a): There is a difference in fear scores between the experimental group in which virtual reality glasses were used during vaccination administration and the control group. Hypothesis 0b (H0b): There is no difference in anxiety scores between the experimental group in which virtual reality glasses were used during vaccination administration and the control group. Hypothesis 1b (H1b): There is a difference in anxiety scores experienced between the experimental group in which virtual reality glasses were used during vaccination administration and the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
February 13, 2021
CompletedFirst Posted
Study publicly available on registry
February 16, 2021
CompletedFebruary 16, 2021
February 1, 2021
4 months
February 13, 2021
February 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Child Fear Scale
This scale is a one-item self-report measure for measuring pain-related fear in children. This one-item scale consists of five sex-neutral faces. It ranges from a no fear (neutral) face on the far left to a face showing extreme fear on the far right. It can be used for children aged 5-10 years.
with an average interval of three to five minutes
The Children's Anxiety Scale-State Scale
It assesses children's anxiety in clinical settings and uses before medical procedures. The Children's Anxiety Scale-State Scale is drawn like a thermometer with a bulb at the bottom, also includes horizontal lines at intervals going up to the top. Children are asked to mark how he/she feel "right now" to measure state anxiety. Scores range from 0 to 10. It validated at children aged 4-10 years during an intravenous procedure.
with an average interval of three to five minutes
Study Arms (2)
Experimental Group
EXPERIMENTALThe Experimental Group watched cartoons with virtual reality glasses during vaccination applications.
Control Group
NO INTERVENTIONPre-test and post-tests were applied to the non-intervention group
Interventions
To the experimental group: Before the vaccine administration; * Children's Fear Scale, and Children's Anxiety Scale-State Scale was applied to the student. * Cartoons and virtual reality glasses that the student wanted to watch were prepared. * While the nurse was preparing the vaccines, the student was put on virtual reality glasses and the distance settings of the lenses were adjusted and the cartoons he chose to watch during the vaccination applications started to be shown. Since virtual reality glasses can cause anxiety attacks manifested by nausea in some children, this was also tested beforehand. It took about two minutes to administer the vaccine and watch cartoons. Those applied after the vaccine administration; \- Children's Fear Scale, and Children's Anxiety Scale-State Scale was applied to the student.
Eligibility Criteria
You may qualify if:
- Parental consent
- Student's willingness to participate in the research
- The student does not have a mental or neurological disability
- Not being able to communicate
- The student does not have a chronic illness
- The student does not have an illness that causes acute or chronic pain
- The student has not used any analgesic medication in the last 24 hours.
You may not qualify if:
- Lack of parental consent
- Student's unwillingness to participate in the research
- The student has a mental or neurological disability
- The student has a communication disability
- The student has a chronic illness
- The student has an illness that causes acute or chronic pain
- The student's use of medication that will have an analgesic effect in the last 24 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
DIRECTORATE OF PROVINCIAL EDUCATION, and PROVINCIAL HEALTH DIRECTORATE
Ordu, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
İlknur KAHRİMAN, Assoc. Prof.
Karadeniz Technical University
- PRINCIPAL INVESTIGATOR
Zila Ö KIRBAŞ, Master
Karadeniz Technical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
February 13, 2021
First Posted
February 16, 2021
Study Start
September 1, 2019
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
February 16, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 12 months after publication
- Access Criteria
- Relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.